Alternatives to Neuralink

Developing soft, stretchable brain-computer interface platforms.

Brain-computer interface for restoring communication and mobility for people with paralysis.

Develops advanced brain-computer interfaces (BCIs) to restore function and independence for individuals with neurological disorders.

Developing a brain-computer interface for high-bandwidth neural data acquisition and stimulation.

Non-invasive brain measurement technology for accessible brain health insights.

Developing a digital pill to rebalance brain networks using imperceptible micro-stimulations.

Developing advanced neurotechnology for understanding and enhancing cognitive function.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

Developing advanced brain-computer interface (BCI) technology for immersive gaming and interactive applications.

Develops advanced brain-computer interfaces for neurological disorder treatment.

Digitizing human brain abilities for universal accessibility and expanded human capabilities.

WeNeuro AI is developing AI-powered tools to enhance human cognitive abilities and learning.

Developing a cortical visual prosthesis to restore functional vision for the severely blind.

OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.

Develops a brain-computer interface for treating epilepsy.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Neurotechnology company developing real-time nervous system regulation tools using science-based audio.

Developing wearable brain imaging systems using quantum sensing technology.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

Developing a novel therapeutic approach for Alzheimer's disease.

AI-powered smart contact lens capable of projecting information directly into the user's field of vision, merging vision, health monitoring, and biosensing.

Digital pathology imaging technology and AI-driven precision pathology software.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI software solutions connecting people and technology via wearables and biosensors, transforming sensory data into actionable insights.

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer for optimal heart disease treatment.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Redefining kidney stone treatment with an aspiration-based stone removal system.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.

AI-powered breast cancer detection and risk assessment solutions.

Developing a minimally invasive, one-time outpatient therapy for obesity treatment.

Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.

Swapping out silicon for lab-grown brains to power AI.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing ultrasound-mediated nonviral genetic medicines.

A medical device company offering a comprehensive, swallowable gastric balloon program for weight loss.

Pioneering vision restoration therapies for severe retinal degenerations.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing advanced vision restoration technology through a retinal implant.